Not Tagged
Not Tagged
['biomarker']
dr. payman ghasemi will be presenting a deep learning approach utilizing clinical and molecular data for identifying prognostic biomarkers in patients treated with immune checkpoint inhibitors: an orien pan-cancer study - 2022 annual meeting, june 3 7. 
Our mission is to design, develop, and translate state-of-the-art patient-centered machine and deep learning algorithms for oncology.